Diabetes affects more than 100 million citizens of the United States with a large section of the population either experiencing type-2 diabetes or prediabetes that might lead to the development of type-2 diabetes (“New CDC report,” 2016). A great variety of treatments and diagnostic techniques have been researched and proposed over the last few decades in an attempt to find an effective and safe resolution to this issue. One such treatment includes a food-diverting operation designed specifically as a solution to type-2 diabetes. This paper will provide an overview of the treatment, and the clinical findings revealed by the research. Food Diversion as a Type-2 Diabetes Treatment Essay
In the introductory section, the authors of the research paper state that bariatric operations have previously shown to be highly effective when attempting to induce a remission of type-2 diabetes in the patient (Fried et al., 2017; Ren, Duan, & Cao, 2018). Such operations include procedures designed to divert food and biliopancreatic secretions to the distal small bowel. More sophisticated operations have recently been developed specifically for non-morbidly obese patients. The paper specifically focuses on patients with BMI between 25 and 35 kg/m2. Side-to-side jejunoileal anastomosis was originally added to the procedure of sleeve gastrectomy as a method of weight loss enhancement. However, this research paper examines its potential use for treatment of type-2 diabetes in patients within the previously stipulated BMI range (Melissas et al., 2017).